Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
With
National Institute on Drug Abuse (NIDA)
This study has 3 specific aims:
Aim 1 is to develop clinical decision support that assists primary care providers in carrying out a brief intervention.
Aim 2 is to assess the impact of the SUSIT on dose of substance use brief intervention received by patients.
Aim 3 is to gather preliminary evidence on the efficacy of the SUSIT approach for reducing moderate-risk drug use.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Substance use screening results (collected using the tablet-based screening tool) indicating current moderate risk drug use, based on a substance specific involvement score (SSIS) indicating current (past 3 months) use of at least one drug with a moderate risk level (SSIS 4-26), in the absence of any high-risk drug or alcohol use (SSIS 27+);
Presenting for visit with a participating PCP
You may not be if
Prior participation in the study (i.e. participation in the SO study phase would preclude participation in the SUSIT phase);
Attending a formal addiction treatment program (not including informal treatment such as Alcoholics Anonymous, Narcotics Anonymous), in the past 3 months;
Pregnant (based on self-report).
Clareo Health | Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings
